The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors

Inclusion Criteria

• •1. Women in Colorado treated for Stage 0 to III estrogen receptor-positive breast cancer who have completed primary cancer treatment (surgery, chemotherapy, and/or radiation) and within the past 2.5 years, have been prescribed anti-hormonal therapy
• •2. Take their anti-hormonal therapy medication at least occasionally and have at least 1 more year left on their prescription
• •3. Report at least 1 factor that makes taking their anti-hormonal therapy medication difficult
• •4. Have internet access